Basic Information
Gray Matter is a preclinical biotechnology company with research pipelines in the fields of cognitive decline, age-related central nervous system disorders, and anti-aging. Gray Matter is a member of the Lactocore Group, which leverages deep expertise in regulatory peptides, including mammalian regulatory peptides, and a proprietary computer-aided discovery engine to develop novel peptide-based therapies for stress-related metabolic disorders.
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios

